|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,492.80 INR | +1.41% |
|
+2.95% | -6.23% |
| 11/03 | Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3% | MT |
| 11/03 | Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences | RE |
Share class: Hester Biosciences Limited
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 85,06,865 | 27,86,978 ( 32.76 %) | 0 | 32.76 % |
Major shareholders: Hester Biosciences Limited
| Name | Equities | % | Valuation |
|---|---|---|---|
10.48
%
| 8,91,508 | 10.48 % | 12 M ₹ |
8.203
%
| 6,97,820 | 8.203 % | 9 M ₹ |
8.186
%
| 6,96,340 | 8.186 % | 9 M ₹ |
5.775
%
| 4,91,300 | 5.775 % | 7 M ₹ |
4.741
%
| 4,03,320 | 4.741 % | 5 M ₹ |
4.71
%
| 4,00,635 | 4.71 % | 5 M ₹ |
4.678
%
| 3,97,989 | 4.678 % | 5 M ₹ |
Biolink Healthcare Ltd.
2.925
%
| 2,48,838 | 2.925 % | 3 M ₹ |
2.883
%
| 2,45,248 | 2.883 % | 3 M ₹ |
2.684
%
| 2,28,354 | 2.684 % | 3 M ₹ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| Individuals | 59.33% |
| Other | 3.96% |
| Governments | 1.04% |
| Unknown | 35.67% |
Based on 1000 largest holdings
Geographical origin of shareholders
Individuals
| 59.33% |
India | 5% |
Based on 1000 largest holdings
Employees
562
Sector
Pharmaceuticals
Calendar
30/05 -
Earnings release - Annual 2026
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















